We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.08B
AUM Growth
+$298M
Cap. Flow
+$91.4M
Cap. Flow %
2.97%
Top 10 Hldgs %
29.39%
Holding
2,686
New
1,350
Increased
669
Reduced
478
Closed
12

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.9M
2
PEP icon
PepsiCo
PEP
+$6.06M
3
NVDA icon
NVIDIA
NVDA
+$5.4M
4
MSFT icon
Microsoft
MSFT
+$4.52M
5
UNH icon
UnitedHealth
UNH
+$3.85M

Top Sells

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$8.26M
2
HDB icon
HDFC Bank
HDB
+$4.53M
3
HSBC icon
HSBC
HSBC
+$4.45M
4
IBN icon
ICICI Bank
IBN
+$3.79M
5
BHP icon
BHP
BHP
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Financials 12.32%
3 Consumer Discretionary 8.41%
4 Healthcare 7.24%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALMS
2626
Alumis Inc
ALMS
$3.57B
$451 ﹤0.01%
+113
New +$465
INSP icon
2627
Inspire Medical Systems
INSP
$1.42B
$446 ﹤0.01%
6
-1,617
-100% -$164K
AGL icon
2628
Agilon Health
AGL
$1.64B
$440 ﹤0.01%
17
-568
-97% -$21.5K
WK icon
2629
Workiva
WK
$2.94B
$431 ﹤0.01%
+5
New +$376
UA icon
2630
Under Armour Class C
UA
$2.92B
$387 ﹤0.01%
+80
New +$447
MLYS icon
2631
Mineralys Therapeutics
MLYS
$2.35B
$380 ﹤0.01%
+10
New +$216
HTLD icon
2632
Heartland Express
HTLD
$1.11B
$378 ﹤0.01%
+45
New +$381
TARS icon
2633
Tarsus Pharmaceuticals
TARS
$2.56B
$357 ﹤0.01%
+6
New +$295
HCAT icon
2634
Health Catalyst
HCAT
$154M
$353 ﹤0.01%
+124
New +$424
MGRC icon
2635
McGrath RentCorp
MGRC
$2.94B
$352 ﹤0.01%
+3
New +$362
TBRG
2636
DELISTED
TruBridge
TBRG
$343 ﹤0.01%
+17
New +$358
ATYR
2637
aTyr Pharma
ATYR
$46.4M
$334 ﹤0.01%
+462
New +$2.09K
CMDB
2638
Costamare Bulkers Holdings
CMDB
$457M
$317 ﹤0.01%
+22
New +$226
TDAY
2639
USA Today Co
TDAY
$1.23B
$302 ﹤0.01%
+73
New +$293
SABR icon
2640
Sabre
SABR
$656M
$277 ﹤0.01%
+151
New +$356
IAS
2641
DELISTED
Integral Ad Science
IAS
$275 ﹤0.01%
+27
New +$234
REPL icon
2642
Replimune Group
REPL
$814M
$273 ﹤0.01%
+65
New +$415
BHVN icon
2643
Biohaven
BHVN
$2.16B
$271 ﹤0.01%
+18
New +$262
RM icon
2644
Regional Management Corp
RM
$384M
$234 ﹤0.01%
+6
New +$226
CRBG icon
2645
Corebridge Financial
CRBG
$14.1B
$225 ﹤0.01%
+7
New +$239
VREX icon
2646
Varex Imaging
VREX
$460M
$224 ﹤0.01%
+18
New +$178
SARO
2647
StandardAero Inc
SARO
$9.54B
$219 ﹤0.01%
+8
New +$224
LOVE icon
2648
LoveSac
LOVE
$239M
$204 ﹤0.01%
+12
New +$223
MOV icon
2649
Movado Group
MOV
$812M
$190 ﹤0.01%
+10
New +$173
SHEN icon
2650
Shenandoah Telecom
SHEN
$632M
$188 ﹤0.01%
+14
New +$192

Similar funds

Quadrant Capital Group's Q3 2025 Portfolio in Review

As of Q3 2025, Quadrant Capital Group held 2,686 positions worth $3.08B, up 11% from $2.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Quadrant Capital Group's Q3 2025 filing shows 1,350 new, 669 increased, 478 reduced and 12 closed positions. Its largest new stake was Coupang: 57,787 shares worth $1.86M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $8.26M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Quadrant Capital Group's largest Q3 2025 buy was Coupang: 57,787 shares worth $1.86M.
  • Quadrant Capital Group added most to Apple in Q3 2025, an estimated $11.9M increase.
  • Quadrant Capital Group's biggest Q3 2025 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $8.26M.
  • Quadrant Capital Group fully exited Ansys in Q3 2025, selling an estimated $891K.
  • Quadrant Capital Group's ten largest holdings make up 29% of its $3.08B portfolio in Q3 2025.
  • Quadrant Capital Group opened 1,350 new positions and closed 12 in Q3 2025.
  • Quadrant Capital Group's portfolio value rose 11% quarter-over-quarter to $3.08B.

Based on Quadrant Capital Group's 13F filing for Q3 2025, filed 13 Nov 2025.